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http://jcmr-online.com/content/16/1/64RESEARCH Open AccessCardiovascular magnetic resonance
characterization of left ventricular non-compaction
provides independent prognostic information in
patients with incident heart failure or suspected
cardiomyopathy
Guha Ashrith1*, Dipti Gupta2, Janel Hanmer3 and Robert M Weiss4Abstract
Background: With recent advances in imaging methods, detection of LVNC is increasingly common. Concomitantly,
the prognostic importance of LVNC is less clear.
Methods: We followed 42 patients (63% male, age 44 ± 15 years) with incident heart failure or suspected
cardiomyopathy, in whom cardiovascular magnetic resonance (CMR) yielded a diagnosis of LVNC, for 27 ± 16 months.
Results: LVNC was preferentially distributed among posterolateral segments, with apical predominance. Patients with
maximum non-compacted-to-compacted thickness ratio (NC:C) < 3 improved by 0.9 ± 0.7 NYHA Class, compared to
0.3 ± 0.8 for patients with NC:C > 3 (p = 0.001). In 29 patients with baseline LVEF < 0.40, there was an inverse correlation
between NC:C ratio, and the change in LVEF during follow-up. Tachyarrhythmias were observed in 42% of patients with
LGE, and in 0% of patients without LGE (p = 0.02). In multivariate analysis, arrhythmia incidence was significantly higher
in patients with LGE, even when adjusted for LVEF and RVEF.
Conclusions: CMR assessments of myocardial morphology provide important prognostic information for patients with
LVNC who present with incident heart failure or suspected cardiomyopathy.
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Isolated left ventricular (LV) non-compaction (NC)
comprises a cardiac phenotype characterized by abun-
dant muscular trabeculation overlying a thin layer of
normal-appearing compacted LV myocardium. Early
reports emphasized the rarity of the condition, familial
inheritance, and high incidence of systolic dysfunction,
malignant arrhythmias, and thromboembolic events,
primarily in children [1].
More recently, LVNC has been recognized as a clinical
phenotype with significant genetic [2] and prognostic
heterogeneity [3]. Advances in imaging technology and* Correspondence: gashrith@houstonmethodist.org
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unless otherwise stated.increased diagnostic vigilance have led to more frequent
detection of a non-compaction phenotype in adults, using
criteria that vary between reports [4-6]. Predictably, the
prognostic significance of a finding of LVNC varies widely,
and may depend on the severity of co-existing structural
heart disease [7-10]
The diagnosis of LVNC is usually made using a binary
criterion, i.e. “present” or “absent”. However, the severity
of hypertrabeculation, as well as the severity of thinning
of underlying compacted myocardium, can vary widely
among patients with LVNC. In addition, it is known that
some patients demonstrate fibrosis in the compacted layer
of myocardium [11,12], a finding that correlates with the
severity of left ventricular systolic dysfunction [13]. How-
ever, the independent prognostic importance of myocar-
dial fibrosis in patients with LVNC has not been reported.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Baseline characteristics
Characteristics n = 42
Age* 44 ± 15
Caucasian, n (%) 37(88)
Male Gender, n (%) 27(64)
LVEF* 36 ± 15
RVEF* 44 ± 14
Maximum NC/C ratio* 3.6 ± 0.8
Number of NC segments* 5.9 ± 1.8
Initial NYHA Class, n (%)
I 2(5)
II 14(33)
III 24(57)
IV 2(5)
% of LGE* 13 ± 12
LVEDVI(ml/m2)* 131 ± 36
LV Mass Index(gm/m2)* 62 ± 29
Medication Use, n (%)
-β Blockers 33(79)
-ACE Inhibitors/ARBs 35(83)
-Loop Diuretics 21(50)
-Aldosterone Antagonists 16(38)
-Digoxin 10(24)
*Mean ± SE; ARBs angiotensin receptor blockers.
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of LVNC, along with the presence of LGE, would correl-
ate with clinical outcomes in patients with incident heart
failure or suspected cardiomyopathy.
Methods
This retrospective study was approved by the Institu-
tional Review Board at the University of Iowa.
Patient selection
We reviewed all adult cardiovascular magnetic reson-
ance (CMR) clinical reports the University of Iowa Hos-
pitals and Clinics between January 1, 2004 and March
30, 2011 (N = 994). Inclusion in the present study re-
quired a diagnosis of incident heart failure or a first
presentation for suspected cardiomyopathy, and a CMR
diagnosis of LVNC, based on the following criteria: i)
non-compacted-to-compacted (NC:C) layer thickness ra-
tio of ≥ 2.3 at end-diastole in at least two short-axis
CMR slices, ii) absence of other congenital heart disease
or coronary heart disease, iii) availability of follow-up
clinical data. Flow limiting coronary artery stenoses were
excluded by coronary angiography (N = 30), or by myo-
cardial perfusion imaging (N = 12).
We identified 42 patients who met all study criteria.
Four additional patients who met MRI criteria for LVNC,
but for whom follow-up was not available, were excluded
from further study. Patient records were reviewed for
initial clinical presentation, family history, past medical
history, NYHA functional class and medication use.
Clinically indicated transthoracic echocardiography, which
was not necessarily directed at detection of LVNC, was
performed in all study subjects prior to CMR evaluation,
and at least once during follow-up.
Patient outcomes
Four categories of patient outcomes were assessed:
change in LV systolic function, change in symptom class,
incidence of tachyarrhythmias, and non-elective hospital
admissions for cardiac causes.
Changes in LV systolic function were assessed by com-
paring echocardiographic measurements of LV ejection
fraction (EF) at the time of CMR to subsequent echocar-
diographic LVEF at the time of latest follow-up. CMR
measurements were not used for this comparison because
a significant number of patients did not undergo follow-
up CMR examination.
Changes in symptom status were ascertained from
the electronic medical record, using New York Heart
Association (NYHA) classification observed at the time
of CMR study, and at the time of latest follow-up.
All hospital admissions for the study group were
reviewed using the electronic medical record. Admissions
for which the primary indication was a change in cardiacclinical status, e.g. heart failure or symptomatic arrhythmia,
were included as endpoints. Admissions for non-cardiac
indications, and elective admissions for cardiac causes,
e.g. elective device implantation or anticoagulation bridg-
ing, were not included in this study endpoint.
Arrhythmias were ascertained from the electronic
medical record, utilizing reports from electrocardiograms
(ECG), ambulatory ECG monitors, and intracardiac device
interrogation reports. For the present study, arrhythmias
included supraventricular tachyarrhythmias, sustained
or nonsustained ventricular tachycardia, and ventricular
fibrillation. Sinus arrhythmias and electronically paced
rhythms were not included in the arrhythmia endpoint.
CMR acquisition
CMR was performed on a 1.5 Tesla scanner (AvantoR;
Siemens, Erlangen, Germany) using a phased-array sur-
face coil. Cine images were acquired using a True-FISP
pulse sequence in long-axis planes and in contiguous
8-mm short-axis slices, which encompassed the whole
heart. A total of 35/42 patients underwent imaging be-
fore, and 10 minutes after, administration of intraven-
ous Gd-DTPA (0.1 mmol/kg), for assessment of late
gadolinium enhancement (LGE). Images were acquired
using inversion-recovery fast gradient-echo pulse sequences
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Figure 1 Imaging left ventricular non-compaction in a single
patient. A: Short-axis echocardiogram at the level of the chordae
tendineae, demonstrating normal-appearing myocardium. B: Apical
4-chamber echocardiogram acquired during early systole, depicting
blood flow out of apical sinusoids (blue). C: Short-axis mid-ventricular
CMR image, demonstrating abundant trabeculation overlying a very
thin compacted myocardial layer in the lateral left ventricular (LV) wall.
Red bar: trabecular thickness; white bar: compacted wall thickness.
D: 4-chamber CMR image depicting LVNC extending from the apical
septum clockwise to the lateral LV wall. RV: right ventricle.
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were optimized individually to null normal myocardium.
CMR image analysis
Ventricular volumes, mass, and systolic function were
analyzed with QMass® MR 6.2.1 software (Medis, Leiden,
Netherlands). LV volumes and mass were indexed to
body surface area. Images were analyzed using the stand-
ard 16-segment model [14] in short-axis slices. The ap-
ical segment, which did not include any of the LV blood
pool, was not included in the analysis. Quantitative LGE
analysis was done by selecting a “normal” region of
interest averaging 50 mm2 within a region unaffected by
LVNC, usually in the interventricular septum. Regions
which displayed signal intensity > 5 standard deviations
above the mean signal intensity of the normal region
were designated “positive” for the presence LGE, accord-
ing to a previously published convention [13]. Trabecu-
lations were excluded from the quantification of LGE
due to difficulty of assessment of LGE close to the blood
pool. Inter-observer variability was assessed for LVEDV,
signal intensity of the region of interest used for assess-
ment of LGE, and maximum NC:C ratio, by two observers
blinded to one another’s findings.
Statistical analyses were performed using SPSS 20 soft-
ware. The Chi-square test or Fisher’s exact test was used
to analyze categorical variables (Fisher’s exact was used
if the expected number of events in any cell was <5). In-
dependent t-test was used to compare continuous vari-
ables between groups. Paired t-test was used to compare
NYHA class before and after completion of the study
period. Continuous variables are presented as mean ±
SD, and categorical variables as N (%). Logistic multi-
variate regression with exact inference, two-way repeated
measures ANOVA and Pearson Rank Correlation tests
were used to assess the association between MRI charac-
teristics and clinical outcomes. Intraclass correlation be-
tween raters was estimated using a two-way random
effects model. All statistical tests were two-sided, with
p-values ≤ 0.05 considered statistically significant.
Results
Demographic, clinical, and CMR characteristics of the
patients are listed in Table 1. Most patients were in
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Figure 2 Anatomical distribution of LVNC. A: Frequency of LVNC among all 42 patients, according to the 16-segment model (ref. 14). B: Key to
segment nomenclature (from ref. 14). C: Circumferential and longitudinal distribution of LVNC, grouped by region.
Table 2 Baseline characteristics in patients classified on
the basis of severity of non-compaction
Characteristics NC:C >3.0 (n = 29) NC:C ≤ 3.0(n = 13)
Age 44 ± 14 44 ± 18
Caucasian, n (%) 25(89) 12(92)
Male Gender, n (%) 21(72) 8(62)
LVEF 0.34 ± 0.17 0.37 ± 0.14
RVEF 0.45 ± 0.14 0.40 ± 0.14
% LGE in C-myocardium 11 ± 12 10 ± 11
Number of NC segments 6.3 ± 1.7 5.0 ± 1.8*
LVEDVI(ml/m2) 132 ± 36 127 ± 38
LV Mass Index(gm/m2) 70 ± 28 60 ± 29
*p < 0.05 vs. NC:C > 3.0.
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for heart failure, at study outset. Duration of follow up
was 27 ± 16 months.
CMR findings
Representative echocardiographic and CMR images from
a patient with LVNC are shown in Figure 1.
Anatomical distribution of LVNC
Non-compaction was present in 248/672 (41%) of myo-
cardial segments, or 5.8 ± 1.8 segments per patient (range:
3-10). LV apical segments most often demonstrated non-
compaction, and basal segments were least often affected.
Circumferential distribution favored anterolateral and
inferolateral segments, whereas septal involvement was
rare (Figure 2).
Severity of LVNC
NC:C ratio was > 3.0 in 29/42 patients. At study entry,
patients with NC:C > 3.0 also had greater anatomic extent
of LVNC than patients with NC:C ≤ 3.0 (Table 2). Other
clinical and imaging features were similar between pa-
tients with NC:C > 3.0 and those with NC:C ≤ 3.0.
Late gadolinium enhancement
LGE in compacted myocardium underlying LVNC was
observed in at least one myocardial segment in 26/35
patients who received Gd-DTPA (Figure 3). There was amodest inverse correlation between the absolute amount
of LGE and baseline LVEF (Figure 4; Additional file 1).
Patients with LGE also had higher LVEDVI and LV mass
than patients without LGE (Table 3).Interobserver variability
Two observers blinded to one another’s findings per-
formed measurements of the LVEDV, signal intensity of
the region of interest used for assessment of LGE, and
maximum NC:C ratio. There was very good agreement
between observers for all three parameters (r2 > 0.90 for
all; intra-class correlation = 0.99, 0.94 and 0.98 respectively
(Additional file 2: Figure S2).
A B
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Figure 3 Late gadolinium enhancement. A: Short-axis phase-sensitive inversion recovery CMR image from a patient with extensive LGE (solid
arrows). A still-frame True-FISP image can be viewed in Additional file 2: Figure S1. Contractile function in the region of myocardium with LGE
can be viewed in the Additional file 1. B: Short-axis phase-sensitive inversion recovery image from a patient without LGE. Dashed arrows indicate
epicardial fat. LV left ventricle; RV right ventricle.
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Changes in LV systolic function
Of the 29 patients with impaired baseline LV systolic
function (echocardiography, LVEF < 0.40), 10 improved
their LVEF by ≥ 0.10 during follow-up (echocardiography,
737 ± 476 days after initial CMR acquisition).Change in cardiac symptom status
For all study patients, NYHA class was 2.6 ± 0.6 at study
outset (range: 1 – 3), and 2.1 ± 0.7 at the time of latest
follow-up (p < 0.001).
There were 34 non-elective hospitalizations for cardiac
causes in 18 patients. Tachyarrhythmias were detected in
14 patients, 12 of whom had undergone imaging for LGE.
Four patients had supraventricular arrhythmias, one had0.00
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Figure 4 Extent of transmural LGE vs. baseline global LV systolic func
CMR-derived LVEF.ventricular fibrillation, three had sustained ventricular
tachycardia, and 6 had nonsustained ventricular tachy-
cardia. Four patients underwent arrhythmia ablation.
Twelve patients underwent ICD implantation for clin-
ical indications, 288 ± 92 days after index MRI. Four pa-
tients experienced at least one appropriate ICD shock.
There were no deaths, transplantation or ventricular
assist device implantations during the follow up period.Relationship between CMR findings and clinical outcomes
Changes in LV systolic function
Baseline LVEF, LVEDV, and LVESV did not correlate sig-
nificantly with the maximum severity of non-compaction
(NC:C ratio; p ≥ 0.15 for each comparison) or the ana-
tomic extent of LVNC (# affected segments; p = 0.30).30 40 50
ransmural LGE(%)
0.18
.01
tion. There is a modest inverse correlation between extent of LGE and
Table 3 Baseline characteristics in patients classified on
the basis of presence of LGE
Characteristic LGE present (n = 26) LGE absent (n = 9)
Age 42 ± 16 42 ± 12
Caucasian, n (%) 22(85) 9(100)
Male Gender, n (%) 21(81) 2(22)
LVEF 30 ± 12 48 ± 10*
RVEF 40 ± 13 51 ± 9*
Maximum NC/C ratio 3.6 ± 0.8 3.3 ± 0.8
Number of NC segments 6.0 ± 1.6 5.1 ± 2.0
LVEDVI(ml/m2) 141 ± 36 96 ± 21*
LV Mass Index(gm/m2) 72 ± 30 50 ± 23*
*p < 0.05 vs. LGE present.
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NC:C ratio of > 3.0 as candidate predictor of improvement
in LVEF ≥ 0.10. There was an inverse correlation between
maximum NC:C ratio, and change in LVEF during
follow-up (r2 = 0.19, p = 0.001) (Figure 5). In patients
with baseline LVEF < 0.40, there was a trend toward in-
verse correlation between LGE, and change in LVEF
during follow-up (r = -0.35, p = 0.06).Symptom status
During follow-up, patients with maximum NC:C ratio ≤ 3
improved by 0.9 ± 0.8 NYHA Class, compared to 0.3 ± 0.9
for patients with NC:C > 3 (p = 0.001) (Figure 6).-0.3
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Figure 5 Severity of non-compaction at baseline forecasts changes in
29 patients who had baseline LVEF < 0.40.Arrhythmia
The anatomic extent of LVNC, grouped by quartiles,
was not significantly correlated with the likelihood of
arrhythmia. Patients with LGE in compacted myocardium
were more likely to incur clinically significant arrhythmia,
when compared to patients without LGE (42% vs. 0;
p = 0.02; Figure 7). In separate logistic multivariate analyses,
LGE remained a significant predictor of clinically significant
arrhythmia even after adjusting for LVEF (LGE p = 0.03;
LVEF p = 0.53), RVEF (LGE p = 0.01; RVEF p = 0.96), and
both LVEF and RVEF (LGE p = 0.03; LVEF p = 0.39; RVEF
p = 0.55). ICD shocks for ventricular tachycardia (n = 3) or
ventricular fibrillation (n = 1) occurred in 4/9 patients with
LGE who underwent ICD implantation, and in 0/3 patients
without LGE who underwent ICD implantation (p =NS).
Hospital admission
Non-elective hospitalizations for cardiac causes were more
likely in patients with LGE than in patients without LGE
(0.8 ± 1.0 vs. 0.2 ± 0.3 per patient; p = 0.04).
Discussion
The most important finding of this study is that, in pa-
tients with incident heart failure or suspected cardiomy-
opathy who receive a diagnosis of LVNC, CMR-based
morphologic features of the LV impart important prog-
nostic information with respect to recovery of LV systolic
function, symptom status, and incidence of tachyarrhyth-
mias. In patients with newly recognized or suspected car-
diomyopathy, the ability to forecast responses to standard4 4.5 5 5.5
 NC:C Ratio
echocardiographic LVEF during follow-up. Data are shown for the
00.4
0.8
1.2
1.6
NC:C < 3 NC:C > 3
ΔNYHA Class
*
Figure 6 Severity of non-compaction forecasts changes in symptom status. Patients with less severe non-compaction were more likely to
improve functional class than patients with more severe non-compaction. NC:C =maximal non-compacted layer thickness-to-compacted layer
thickness ratio. NYHA Class = New York Heart Association Functional Class. *p < 0.05.
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useful. For example, a decision to refer a patient for
resynchronization or implantable cardioverter-defibrillator
therapy can depend on responses to therapy over time.
We found that changes in LVEF during follow-up were
correlated, inversely, with the maximum severity of non-
compaction. We also found that changes in symptom sta-
tus correlated inversely with the severity of LVNC.Prognostic importance of LGE
Patients with the LVNC phenotype are putatively at risk
of death, heart failure decompensation, arrhythmias, and
transplantation. Two recent studies reported rates of
heart failure hospitalizations (30-38%), arrhythmias (20-
30%) in patients with the LVNC phenotype [4,7] which
are comparable to our findings. However, the prognosis
varies widely among patients with LVNC, which has
tended to be reported as “present” or “absent” [15]. Our
findings extend this body of knowledge, by stratifying+ LGE
Figure 7 Late gadolinium enhancement at baseline forecasts arrhythm
in compacted myocardium. *p < 0.05.the likelihood of hospitalization or arrhythmia, accord-
ing to the presence or absence of LGE.
Our findings in patients with LVNC parallel previously
reported trends for the broader population of patients
with dilated cardiomyopathy, where the presence of LGE
portends worse outcome [16,17]. Importantly, we found
that the presence of LGE in patients with LVNC was an
independent predictor of arrhythmia or non-elective hos-
pital admission, whereas baseline LVEF was not, in our
study group with restricted inclusion criteria.
Limitations
This study has the limitations of a retrospective study.
There could be selection bias since the patients were
seen in a tertiary care center and most of them were re-
ferred for incident heart failure. The sample size was small,
but sufficient to provide some prognostic stratification.
Links between CMR findings and clinical outcomes are
presented as correlations or predictors. We are not able to
prove causality of CMR findings for clinical outcomes, since- LGE            
ias during follow-up. +LGE refers to late gadolinium enhancement
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findings are restricted to patients with incident heart failure
or suspected cardiomyopathy, a cohort whose prognosis
may be more diverse than patients with longstanding heart
failure or those who with subclinical disease.
Diagnostic and therapeutic decisions were made on
clinical grounds for all patients included in this retro-
spective study. Clinicians were aware of some CMR find-
ings, which could potentially introduce an element of
bias toward a conclusion that CMR is clinically useful.
However, we did not observe more vigilant diagnostic
follow-up in patients with more severe LVNC. For
example, follow-up echocardiography was performed
542 ± 435 days after index CMR in patients with LGE vs.
585 ± 379 days in patients without LGE (p =NS). Ambula-
tory ECG-monitoring and ICD implantation were per-
formed based on established clinical criteria, which did
not invoke any specific findings from CMR. Most im-
portant, on clinical CMR reports, the NC:C ratio was
not reported, and thus could not have influenced clin-
ical decision-making.
By inclusion only of patients who met established cri-
teria for LVNC, we are not able to determine the prog-
nostic importance of LVNC per se, compared to patients
without LVNC. However, we are able to identify group
of patients, which have mild LVNC, limited anatomic
extent of LVNC, and absence of LGE, who have a better
prognosis with respect to clinical improvement, and who
are at low short-term risk for arrhythmia or non-elective
hospital admission.
Conclusions
In patients for whom CMR provides a diagnosis of LVNC,
there is considerable variability in the severity, anatomic
extent, and association with LGE, each of which correlates
with important clinical outcomes. Larger prospective
studies are needed to determine whether these findings
will be useful to guide therapeutic and preventive deci-
sions in patients with LVNC.
Additional files
Additional file 1: Short-axis cine True-FISP images from the patient
depicted in Figure 3A. The region corresponding to dense LGE in the
lateral LV wall demonstrates systolic thickening and endocardial shortening.
Additional file 2: Figure S1. True-FISP image from the patient depicted
in Figure 3A. Solid arrows delineate compacted myocardium. Dashed arrow
indicates epicardial fat. LV left ventricle; RV right ventricle. Systolic function
can be viewed in the Additional file 2. Figure S2. Interobserver variability.
A: Signal intensity, used to determine presence or absence of LGE. B: Maximum
NC:C layer thickness ratio. C: Left ventricular end-diastolic volume (LVEDV).
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